TP53 and acute myeloid leukemia: These findings suggest that TP53 pathway activation is associated with enhanced venetoclax-induced apoptosis with the downregulation of DRP1 expression, and mutated TP53 allows DRP1 to remain upregulated in the TP53mut AML cells.